|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

,2
* Experimental Oncology Department and
Rome Oncogenomic Center (ROC), Istituto Regina Elena, Rome, Italy; and
Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
2 Correspondence: Istituto Regina Elena, Via delle Messi DOro 156, 00158 Rome, Italy. E-mail: piaggio{at}ifo.it
MicroRNAs (miRs) are 21- to 23-nucleotide RNA molecules that regulate the stability or translational efficiency of target messenger RNAs of proteins involved in cell growth and apoptosis. miR-92 is part of the mir-17–92 cluster, which comprises members with an effect on cell proliferation. However, the role of miR-92 is unknown, and its targets have not been identified. Here, we describe a mechanism through which miR-92 contributes to regulate cell proliferation. Using a miR-92 synthetic double-strand oligonucleotide, we demonstrate that miR-92 increases 32D myeloid cell proliferation and 5-bromo-2-deoxyuridine (BrdU) incorporation and inhibits cell death. The effect is miR-92 specific since the miR-92 antagomir inhibits cell proliferation. Moreover, we show that miR-92 acts by modulating p63-isoform abundance through down-regulatation of endogenous
Np63β. Using luciferase reporters containing p63 3'UTR fragments with wild-type or mutant miR-92 complementary sites, we demonstrate that the wild-type 3'UTR is a direct target of miR-92. Finally, we observed that a miR-92-resistant
Np63β isoform (without 3'UTR) inhibits cell proliferation and parallels the effect of the antagomir. We conclude that one of the molecular mechanisms through which miR-92 increases cell proliferation is by negative regulation of an isoform of the cell-cycle regulator p63.—Manni, I., Artuso, S., Careccia, S., Rizzo, M. G., Baserga, R., Piaggio, G., Sacchi, A. The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.
Key Words: 3'UTR hematopoiesis p53 family small noncoding RNAs
This article has been cited by other articles:
![]() |
G. van Haaften and R. Agami Tumorigenicity of the miR-17-92 cluster distilled Genes & Dev., January 1, 2010; 24(1): 1 - 4. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |